scholarly article | Q13442814 |
P2093 | author name string | Lesley Jones | |
Alis Hughes | |||
P2860 | cites work | Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice. | Q45304186 |
Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum. | Q48723938 | ||
Huntingtin immunoreactivity in the rat neostriatum: differential accumulation in projection and interneurons | Q48736244 | ||
Partial characterisation of murine huntingtin and apparent variations in the subcellular localisation of huntingtin in human, mouse and rat brain | Q49020588 | ||
Nuclear relocation of normal huntingtin | Q73965077 | ||
Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme | Q24311567 | ||
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons | Q24317574 | ||
Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation | Q28246858 | ||
Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways | Q28277799 | ||
Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice | Q28505664 | ||
Neurological abnormalities in a knock-in mouse model of Huntington's disease | Q28508179 | ||
Expression of normal and mutant huntingtin in the developing brain | Q28508248 | ||
Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form | Q28509836 | ||
Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease | Q28589793 | ||
Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain | Q29617982 | ||
Monoclonal antibodies recognize distinct conformational epitopes formed by polyglutamine in a mutant huntingtin fragment | Q30490726 | ||
Localization of rabbit huntingtin using a new panel of monoclonal antibodies | Q30640638 | ||
Huntingtin interacts with cystathionine beta-synthase | Q32120855 | ||
Overview of cell fixatives and cell membrane permeants | Q33546660 | ||
Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease | Q33726473 | ||
Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies | Q33920421 | ||
Characterization and localization of the Huntington disease gene product | Q34662553 | ||
Normal and expanded Huntington's disease gene alleles produce distinguishable proteins due to translation across the CAG repeat. | Q36437616 | ||
Subcellular localization of the Huntington's disease gene product in cell lines by immunofluorescence and biochemical subcellular fractionation | Q36823776 | ||
Is my antibody-staining specific? How to deal with pitfalls of immunohistochemistry. | Q37352171 | ||
Neuroanatomic profile of polyglutamine immunoreactivity in Huntington disease brains. | Q37372681 | ||
Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription | Q40764541 | ||
Analysis of the subcellular localization of huntingtin with a set of rabbit polyclonal antibodies in cultured mammalian cells of neuronal origin: comparison with the distribution of huntingtin in Huntington's disease autopsy brain | Q40859417 | ||
The influence of huntingtin protein size on nuclear localization and cellular toxicity. | Q41035353 | ||
Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates | Q41065635 | ||
The identification of a functional nuclear localization signal in the Huntington disease protein | Q41285600 | ||
Specificity of immunoreactions: the importance of testing specificity in each method | Q41977995 | ||
New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins | Q42664318 | ||
Widespread expression of Huntington's disease gene (IT15) protein product | Q42684112 | ||
Nuclear localization of N-terminal mutant huntingtin is cell cycle dependent | Q44095469 | ||
Huntingtin localization in brains of normal and Huntington's disease patients | Q45295341 | ||
Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. | Q45296558 | ||
Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin | Q45297223 | ||
A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. | Q45298582 | ||
P304 | page(s) | RRN1211 | |
P577 | publication date | 2011-02-16 | |
P1433 | published in | PLOS Currents | Q7119653 |
P1476 | title | Huntingtin localisation studies - a technical review | |
P478 | volume | 3 |